| Serial Number | 77178675 |
| Word Mark | ACCRETAMAB |
| Filing Date | Friday, May 11, 2007 |
| Status | 800 - REGISTERED AND RENEWED |
| Status Date | Wednesday, April 10, 2019 |
| Registration Number | 3653037 |
| Registration Date | Tuesday, July 14, 2009 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 28, 2009 |
| Goods and Services | [Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, pharmaceutical preparations for the treatment of insomnia and other sleep related diseases] |
| Goods and Services | Contract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of host cells; contract extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; providing information in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of host cells; technical consultation in the field of manufacturing technology in the field of host cells; providing technical information in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals technical consultation in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals |
| Goods and Services | Development of new products for others in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; providing technical information in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; technical consultation in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | B - Sec. 8 - Class(es) in a Multiple Class registration |
| Class Status Date | Wednesday, August 5, 2015 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 16, 2007 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 16, 2007 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | KYOWA KIRIN CO., LTD. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | TOKYO JP |
| Party Name | KYOWA HAKKO KIRIN CO., LTD. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | CHIYODA-KU, TOKYO 100-8185 JP |
| Party Name | KYOWA HAKKO KIRIN CO., LTD. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CHIYODA-KU, TOKYO JP |
| Party Name | KYOWA HAKKO KIRIN CO., LTD. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CHIYODA-KU, TOKYO JP |
| Party Name | KYOWA HAKKO KOGYO CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Chiyoda-ku Tokyo 100-8185 JP |
| Event Date | Event Description |
| Wednesday, September 4, 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Wednesday, April 10, 2019 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| Wednesday, April 10, 2019 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| Wednesday, April 10, 2019 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| Monday, April 8, 2019 | TEAS SECTION 8 & 9 RECEIVED |
| Saturday, July 14, 2018 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Wednesday, August 5, 2015 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| Wednesday, August 5, 2015 | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED |
| Wednesday, August 5, 2015 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Wednesday, July 1, 2015 | TEAS SECTION 8 RECEIVED |
| Tuesday, July 14, 2009 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, April 28, 2009 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 8, 2009 | NOTICE OF PUBLICATION |
| Monday, March 23, 2009 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, March 23, 2009 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 24, 2009 | AMENDMENT FROM APPLICANT ENTERED |
| Tuesday, February 24, 2009 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 23, 2009 | PAPER RECEIVED |
| Tuesday, February 10, 2009 | INQUIRY AS TO SUSPENSION MAILED |
| Monday, February 9, 2009 | SUSPENSION INQUIRY WRITTEN |
| Monday, February 9, 2009 | AMENDMENT FROM APPLICANT ENTERED |
| Monday, February 9, 2009 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, February 6, 2009 | PAPER RECEIVED |
| Monday, January 12, 2009 | INQUIRY AS TO SUSPENSION MAILED |
| Sunday, January 11, 2009 | SUSPENSION INQUIRY WRITTEN |
| Thursday, December 11, 2008 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
| Wednesday, November 19, 2008 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Wednesday, June 11, 2008 | LETTER OF SUSPENSION MAILED |
| Wednesday, June 11, 2008 | SUSPENSION LETTER WRITTEN |
| Tuesday, June 10, 2008 | AMENDMENT FROM APPLICANT ENTERED |
| Tuesday, June 10, 2008 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 9, 2008 | PAPER RECEIVED |
| Wednesday, March 26, 2008 | INQUIRY AS TO SUSPENSION MAILED |
| Tuesday, March 25, 2008 | SUSPENSION INQUIRY WRITTEN |
| Sunday, February 24, 2008 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
| Sunday, February 24, 2008 | ASSIGNED TO LIE |
| Friday, August 24, 2007 | LETTER OF SUSPENSION MAILED |
| Friday, August 24, 2007 | SUSPENSION LETTER WRITTEN |
| Friday, August 24, 2007 | ASSIGNED TO EXAMINER |
| Wednesday, May 16, 2007 | NEW APPLICATION ENTERED IN TRAM |